🏛️ Verified NIH Record • Updated 2025-11-21
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer (NCT04624477)
Active Surveillance or Surgery for Primary Management of Very Low Risk Papillary Thyroid Cancer: How Often Are the Long-term Disease Management Goals Achieved?
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University Health Network, Toronto
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, observational, multi-center study examining the long-term outcomes of patients with small, low risk papillary thyroid cancer who offered the choice of active surveillance (close follow-up to monitor for potential disease progression) or immediate surgery.
Who can join: Review the eligibility criteria below.
Location: University of Calgary, Cumming School of Medicine — Calgary, Alberta
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- University of Calgary, Cumming School of Medicine — Calgary, Alberta
- University of British Columbia — Vancouver, British Columbia
- Nova Scotia Health — Halifax, Nova Scotia
- St. Joseph's Healthcare — Hamilton, Ontario
- Lawson Health Research Institute — London, Ontario
- University Health Network — Toronto, Ontario
- Division chirurgie ORL et cervico-faciale — Montreal, Quebec
- CHU de Québec - Université Laval — Québec, Quebec
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Papillary Thyroid Cancer
- Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples — Calgary, Alberta
- Targeted Therapy to Increase RAI Uptake in Metastatic DTC — San Francisco, California
Explore by condition: All Papillary Thyroid Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.